Search Results - T V Martynyuk

Refine Results
  1. 1
    The place of tadalafil in the treatment of PAH in the light of new clinical guidelines of the Eurasian Association of Cardiologists

    The place of tadalafil in the treatment of PAH in the light of new clinical guidelines of the Eurasian Association of Cardiologists by T. V. Martynyuk

    Published 2024-03-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Choice of specific and anticoagulant therapy in patients with newly diagnosed chronic thromboembolic pulmonary hypertension, depending on operability status

    Choice of specific and anticoagulant therapy in patients with newly diagnosed chronic thromboembolic pulmonary hypertension, depending on operability status by Z. S. Valieva, T. V. Martynyuk

    Published 2023-04-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    CASE REPORT ON THE SUCCESSFUL USE OF A NEW SELECTIVE PROSTACYCLIN IP RECEPTOR AGONIST, SELEXIPAG, IN A PATIENT WITH IDIOPATHIC PULMONARY HYPERTENSION

    CASE REPORT ON THE SUCCESSFUL USE OF A NEW SELECTIVE PROSTACYCLIN IP RECEPTOR AGONIST, SELEXIPAG, IN A PATIENT WITH IDIOPATHIC PULMONARY HYPERTENSION by Z. S. Valieva, T. V. Martynyuk

    Published 2019-12-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    COMPARATIVE CLINICAL CHARACTERISTICS OF PATIENTS WITH VARIOUS FORMS OF PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL HEART DISEASE, ACCORDING TO THE CLINICAL CLASSIFICATION

    COMPARATIVE CLINICAL CHARACTERISTICS OF PATIENTS WITH VARIOUS FORMS OF PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL HEART DISEASE, ACCORDING TO THE CLINICAL CLASSIFIC... by S. E. Gratsianskaya, T. V. Martynyuk

    Published 2019-12-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Fixed-dose combination of perindopril and indapamide: perspectives in hypertensive patients with inadequately controlled blood pressure

    Fixed-dose combination of perindopril and indapamide: perspectives in hypertensive patients with inadequately controlled blood pressure by I. E. Chazova, T. V. Martynyuk

    Published 2007-02-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    PULMONARY ARTERIAL HYPERTENSION IN SYSTEMIC CONNECTIVE TISSUE DISEASES: THE CURRENT STATE OF THE PROBLEM

    PULMONARY ARTERIAL HYPERTENSION IN SYSTEMIC CONNECTIVE TISSUE DISEASES: THE CURRENT STATE OF THE PROBLEM by A. V. Volkov, T. V. Martynyuk

    Published 2018-09-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    Changing “portrait” of patients with newly diagnosed idiopathic pulmonary hypertension over the past two decades

    Changing “portrait” of patients with newly diagnosed idiopathic pulmonary hypertension over the past two decades by A. M. Shariya, T. V. Martynyuk

    Published 2024-10-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Results of long-term riociguat therapy, including a switching strategy from sildenafil, in patients with pulmonary hypertension of various genesis

    Results of long-term riociguat therapy, including a switching strategy from sildenafil, in patients with pulmonary hypertension of various genesis by S. A. Musashaykhova, Z. S. Valieva, T. V. Martynyuk

    Published 2023-11-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    OPTIMIZATION OF SPECIFIC THERAPY FOR PULMONARY ARTERIAL HYPERTENSION: THE POSSIBILITIES OF USING ENDOTHELIN RECEPTOR ANTAGONISTS

    OPTIMIZATION OF SPECIFIC THERAPY FOR PULMONARY ARTERIAL HYPERTENSION: THE POSSIBILITIES OF USING ENDOTHELIN RECEPTOR ANTAGONISTS by T. V. Martynyuk, S. N. Nakonechnikov, I. Ye. Chazova

    Published 2017-06-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    New perspectives in pulmonary arterial hypertension treatment: 2009 European recommendations

    New perspectives in pulmonary arterial hypertension treatment: 2009 European recommendations by T. V. Martynyuk, S. N. Nakonechnikov, I. E. Chazova

    Published 2010-04-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    ACCORDING TO THE RESULTS OF THE EUROPEAN CONGRESS OF CARDIOLOGY 2015: NEW VERSION OF GUIDELINES FOR DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION

    ACCORDING TO THE RESULTS OF THE EUROPEAN CONGRESS OF CARDIOLOGY 2015: NEW VERSION OF GUIDELINES FOR DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION by I. Ye. Chazova, T. V. Martynyuk, S. N. Nakonechnikov

    Published 2015-12-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    Calculation of hemodynamics by the Fick method in pulmonary hypertension associated with congenital heart defects

    Calculation of hemodynamics by the Fick method in pulmonary hypertension associated with congenital heart defects by A. A. Shmalts, T. V. Martynyuk, S. N. Nakonechnikov

    Published 2022-05-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    TACTICS FEATURES OF CONDUCTING AND CHOOSING SPECIFIC THERAPY FOR ADULT PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL HEART DISEASE

    TACTICS FEATURES OF CONDUCTING AND CHOOSING SPECIFIC THERAPY FOR ADULT PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL HEART DISEASE by O. A. Arkhipova, T. V. Martynyuk, I. Ye. Chazova

    Published 2018-03-01
    Get full text
    Article

    Save to List
    Saved in:
  14. 14
    OPPORTUNITIES FOR OPTIMIZATION OF DRUG THERAPY BY ENDOTHELIN RECEPTOR ANTAGONISTS FOR THE PATIENT WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION AND ATRIAL SEPTOSTOMY

    OPPORTUNITIES FOR OPTIMIZATION OF DRUG THERAPY BY ENDOTHELIN RECEPTOR ANTAGONISTS FOR THE PATIENT WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION AND ATRIAL SEPTOSTOMY by V. V. Gramovich, A. M. Aleevskaya, T. V. Martynyuk

    Published 2018-12-01
    Get full text
    Article

    Save to List
    Saved in:
  15. 15
    New treatment options for pulmonary arterial hypertension — the first selective IP-receptor agonist selexipag

    New treatment options for pulmonary arterial hypertension — the first selective IP-receptor agonist selexipag by N. V. Ilyin, K. I. Ivanov, T. V. Martynyuk

    Published 2019-12-01
    Get full text
    Article

    Save to List
    Saved in:
  16. 16
    Determinants of prognosis and management of patients with pulmonary hypertension due to left heart disease: a systematic review

    Determinants of prognosis and management of patients with pulmonary hypertension due to left heart disease: a systematic review by I. N. Lyapina, Yu. E. Teplova, T. V. Martynyuk

    Published 2023-03-01
    Get full text
    Article

    Save to List
    Saved in:
  17. 17
    Prostacyclin receptor agonist selexipag in a patient with high-risk idiopathic pulmonary arterial hypertension: a case report

    Prostacyclin receptor agonist selexipag in a patient with high-risk idiopathic pulmonary arterial hypertension: a case report by E. A. Rezukhina, O. V. Rodnenkov, T. V. Martynyuk

    Published 2021-09-01
    Get full text
    Article

    Save to List
    Saved in:
  18. 18
    Economic burden of pulmonary hypertension. Systematic review

    Economic burden of pulmonary hypertension. Systematic review by V. D. Zakiev, T. V. Martynyuk, Yu. V. Kotovskaya

    Published 2024-10-01
    Get full text
    Article

    Save to List
    Saved in:
  19. 19
    Patient and disease characteristics of pulmonary arterial hypertension patients for prostacyclin receptor agonist selexipag treatment initiation

    Patient and disease characteristics of pulmonary arterial hypertension patients for prostacyclin receptor agonist selexipag treatment initiation by E. A. Rezukhina, O. V. Rodnenkov, T. V. Martynyuk

    Published 2023-03-01
    Get full text
    Article

    Save to List
    Saved in:
  20. 20
    Vasoreactivity testing in pulmonary hypertension associated with congenital heart disease

    Vasoreactivity testing in pulmonary hypertension associated with congenital heart disease by A. A. Shmalts, S. V. Gorbachevsky, T. V. Martynyuk, S. N. Nakonechnikov

    Published 2022-10-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: